ArticleJournal of personalized medicine2021

RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer.

Chieh-Ni Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.